PLK1 and neoplasm: This multistage mechanism effectively delivers siRNA against polo-like kinase-1 (siPLK-1), a mitotic regulator overexpressed in cancer cells, and docetaxel to tumors to downregulate expression of PLK-1 and inhibit tumor growth.